Discontinuation of antidepressant medication among Latinos in the USA

Journal of Behavioral Health Services and Research

Volumn 34, Issue 3, 2007, Pages 329-342

  Hodgkin, Dominic ^a   Volpe Vartanian, Joanna ^a   Alegría, Margarita ^b  

^a BRANDEIS UNIVERSITY   (United States)

^b CAMBRIDGE HEALTH ALLIANCE   (United States)

Author keywords

Antidepressant drugs; Depressed patients; Latinos; Medication adherence; Psychotropic medication use

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DEMOGRAPHY; DRUG WITHDRAWAL; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MULTIVARIATE ANALYSIS; PHYSICIAN; PRIVATE HEALTH INSURANCE; PROBABILITY; PSYCHOTHERAPIST; PUBLIC HEALTH INSURANCE; SAMPLE SIZE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DATA COLLECTION; DEPRESSION; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; UNITED STATES;

EID: 34548155296     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11414-007-9070-6     Document Type: Article

References (59)

1. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the global burden of disease study. Science. 1996;274(5288):740-743.
2. Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic medical illnesses. Archives of General Psychiatry. 1995;52(1):11-19.
3. Melfi CA, Chawla A, Croghan TW, et al. Effect of adherence to guidelines for depression treatment on relapse and recurrence in a Medicaid population. Archives of General Psychiatry. 1998;55(12):1128-1132.
4. Maj M, Veltro F, Pivossi R, et al. Patterns of recurrence of illness after recovery of an episode of major depression: a prospective study. American Journal of Psychiatry. 1992;149(6):795-800.
5. Sheehan DV, Eaddy M, Sarnes M, et al. Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine. Journal of Clinical Psychopharmacology. 2004;24(5):544-548.
6. Nemeroff CB. Improving antidepressant adherence. Journal of Clinical Psychiatry. 2003;64(Suppl 18):25-30.
7. Tai-Seale M, Croghan TW, Obenchain R. Determinants of antidepressant treatment compliance: implications for policy. Medical Care Research and Review. 2000;57(4):491-512.
8. Busch SH, Leslie DL, Rosenheck RA. Comparing the quality of antidepressant pharmacotherapy in the Department of Veteran Affairs and the private sector. Psychiatric Services. 2004;55(12):1386-1391.
9. National Committee for Quality Assurance (NCQA). The state of health care quality. Washington, DC: NCQA; 2004.
10. Charbonneau A, Rosen AK, Ash AS, et al. Measuring the quality of depression care in a large integrated health system. Medical Care. 2003;41(5):669-680.
11. Pampallona S, Bollini P, Tibaldi G. Patient adherence in the treatment of depression. British Journal of Psychiatry. 2002;180:104-109.
12. Hansen DG, Vach W, Rosholm JU, et al. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Family Practice. 2004;21(6):623-629.
13. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. Journal of Clinical Psychiatry. 2001;62(Suppl 22):30-33.
14. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica. 2002;105(3):164-172.
15. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants. Journal of the American Medical Association. 2002;288(11):1403-1409.
16. Agency of Health Care Policy and Research. Depression in primary care. Vols. 1 and 2. Rockville, MD: US Department of Health and Human Services; 1993.
17. American Psychiatric Association. Practice guidelines for major depression in adults. American Journal of Psychiatry. 1993;150(Suppl 4):1-26.
18. Pomerantz JM, Finkelstein SN, Berndt ER, et al. Prescriber intent, off-label usage, and early discontinuation of antidepressants: a retrospective physician survey and data analysis. Journal of Clinical Psychiatry. 2004;65(3):395-404.
19. Sleath B, Rubin RH, Huston SA. Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Comprehensive Psychiatry. 2003;44(3):198-204.
20. Sanchez-Lacay JA, Lewis-Fernandez R, Goetz D, et al. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability and adherence issues. Depression and Anxiety. 2001;13(3):118-124.
21. Lewis-Fernandez R, Das AK, Alfonso C, et al. Depression in US Hispanics: diagnostic and management considerations in family practice. Journal of the American Board of Family Practice. 2005;18(4):282-296.
22. Marcos LR, Cancro R. Pharmacotherapy of Hispanic depressed patients: clinical observations. American Journal of Psychotherapy. 1982;36(4):505-512.
23. Wagner GJ, Maguen S, Rabkin JG. Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients. Psychiatric Services. 1998;49:239-240.
24. Guarnaccia PJ, Martinez I. Comprehensive in-depth literature review and analysis of Hispanic mental health issues. Mercerville, NJ: New Jersey Mental Health Institute; 2002.
25. Alegria M, Canino G, Rios R, et al. Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatric Services. 2002;53(12):1547-1555.
26. Breslau J, Kendler KS, Su M, et al. Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychological Medicine. 2005;35:317-327.
27. Marin H, Escobar JI. Special issues in the psychopharmacological management of Hispanic Americans. Psychopharmacology Bulletin. 2001;35(4):197-213.
28. Hough RL, Landsverk JA, Karno M, et al. Utilization of health and mental health services by Los Angeles Mexican Americans and non-Hispanic whites. Archives of General Psychiatry. 1987;44:702-709.
29. Padgett DK, Patrick CP, Burns BJ, et al. Women and outpatient mental health services: use by Black, Latino and white women in a national insured population. Journal of Mental Health Administration. 1994;21:347-360.
30. US Department of Health and Human Services. Mental health: culture, race and ethnicity - a supplement to Mental health: a report of the Surgeon General. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2001.
31. Wang PS, Demler O, Kessler R. Adequacy of treatment for serious mental illness in the United States. American Journal of Public Health. 2002;92(1):92-98.
32. Edlund MJ, Unutzer J, Wells KB. Clinician screening and treatment of alcohol, drug and mental problems in primary care: results from Healthcare For Communities. Medical Care. 2004;42(12):1158-1166.
33. Ormel J, Koeter MWJ, van den Brink W, et al. Recognition, management, and course of anxiety and depression in general practice. Archives of General Psychiatry. 1991;48:700-706.
34. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. Journal of the American Medical Association. 1989;262:914-919.
35. Borowsky SJ, Rubenstein LV, Meredith LS, et al. Who is at risk of nondetection of mental health problems in primary care? Journal of General Internal Medicine. 2000;15(6):383-388.
36. Alegría M, Takeuchi D, Canino G, et al. Considering context, place and culture: the National Latino and Asian American Study. International Journal of Methods in Psychiatric Research. 2004;13(4):208-220.
37. Alegria M, Sribney W, Woo M, et al. Looking beyond nativity: the relation of age of immigration, length of residence, and birth cohorts to the risk of onset of psychiatric disorders for Latinos. Research on Human Development. 2007;in press.
38. Miranda J, Cooper LA. Disparities in care for depression among primary care patients. Journal of General Internal Medicine. 2004;19(2):120-126.
39. Diaz E, Wood SW, Rosenheck RA. Effects of ethnicity on psychotropic medications adherence. Community Mental Health Journal. 2005;41(5):521-537.
40. Alonso M, Val E, Rappoport MH. An open label study of SSRI treatment in depressed Hispanic and non-Hispanic women. Journal of Clinical Psychiatry. 1997;58(1):31.
41. Sleath B, Rubin RH, Wurst K. The influence of Hispanic ethnicity on patients' expression of complaints about and problems with adherence to antidepressant therapy. Clinical Therapeutics. 2003;25(6):1739-1749.
42. Wilson E, Chan AH, Grumbach K, et al. Effects of limited English proficiency and physician language on health care comprehension. Journal of General Internal Medicine. 2005;20(9):800-806.
43. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall; 1980.
44. Ajzen I. The theory of planned behavior. Organizational Behavior and Human Decision Processes. 1991;50(2):179-211.
45. Rosenstock I. Why people use health services. Milbank Memorial Fund Quarterly. 1966;44:94-124.
46. Veazie PJ, Cai S. A connection between medication adherence, patient sense of uniqueness, and the personalization of information. Medical Hypotheses. 2007;68(2):335-342.
47. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behavior. American Psychologist. 1992;47(9):1102- 1114.
48. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens. Clinical Therapeutics. 2000;22(7):858-871.
49. McGuire T. Financing psychotherapy: Costs, effects, and public policy. Cambridge, MA: Ballinger; 1981.
50. Clark T, Sleath B, Rubin RH. Influence of ethnicity and language concordance on physician-patient agreement about recommended changes in patient health behavior. Patient Education and Counseling. 2004;53:87-93.
51. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventive medication. Psychology and Health. 2002;17(1):17-32.
52. Heeringa S, Wagner J, Torres M, et al. Sample designs and sampling methods for the Collaborative Psychiatric Epidemiology Studies (CPES). International Journal of Methods in Psychiatric Research. 2004;13:221-240.
53. Haddad PM. Antidepressant discontinuation syndromes. Drug Safety. 2001;24(3):183-197.
54. Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. Journal of Clinical Psychiatry. 1997;58(7):291-297.
55. Schatzberg AF, Blier P, Delgado PI, et al. Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. Journal of Clinical Psychiatry. 2006;67(Suppl 4):27-30.
56. Alegría M, Cao Z, McGuire TG, et al. Health insurance coverage for vulnerable populations: comparing Asian Americans and Latinos in the United States. Inquiry. 43(3):231-254.
57. Economic Research Initiative on the Uninsured. Ann Arbor, MI: University of Michigan, 2004 data. Available at: http://www.umich.edu/∼eriu/fastfacts/ cps2003_2.html. Accessed February 23, 2007.
58. Lewis-Fernandez R, Kleinman A. Cultural psychiatry. Theoretical, clinical, and research issues. Psychiatric Clinics of North America. 1995;18(3):433-448.
59. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-Americans, Hispanics, and white primary care patients. Medical Care. 2003;41(4):479-489.